Skip to main content

Find Clinical Trials

Home
Conditions
Resectable Stage II-IIIB NSCLC

Clinical trial condition

Resectable Stage II-IIIB NSCLC

Explore clinical trials studying Resectable Stage II-IIIB NSCLC. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Resectable Stage II-IIIB NSCLC trial results

Not Yet Recruiting

A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-small Cell Lung Cancer (NSCLC)

NCT07108816

Conditions: Resectable Stage II-IIIB NSCLC
Locations: Not specified

View Trial Details